Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor regulated at the protein level by oxygen and iron. Under normoxic conditions HIF is degraded, but under hypoxic conditions or ...

A study from the University of Chicago showed a new way to target previously “undruggable” proteins involved in cancer by ...

Sporting regulatory bodies should allow these data to be collected in all matches to assist in our understanding. There are numerous hypoxia-induced, negative physiological perturbations that suggest ...

It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by ...

30 Thus, we used the changes in [HHb] prior to each sprint to estimate the differences in intramuscular and cerebral deoxygenation status induced by RS training in hypoxia and normoxia.

Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development ...

Recent research highlights the potential of targeting the brain’s metabolism to treat Alzheimer’s disease, a condition that ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

The ICMR has formalized a Memorandum of Agreement (MoA) with Zydus for a Phase IIa double-blind, randomized, ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...

Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was ...